Abstract |
Negative allosteric modulators of metabotropic glutamate receptor 5 (mGlu5) showed efficacy in a number of animal models of different CNS diseases including anxiety and depression. Virtually all of the compounds which reached the clinic belong to the same chemotype having an acetylenic linker that connects (hetero)cyclic moieties. Searching for new chemotypes we identified a morpholino-sulfoquinoline derivative (1) by screening our corporate compound deck. The HTS hit showed reasonable affinity and selectivity towards mGlu5 receptors, however, its inferior metabolic stability prevented its testing in vivo. In a chemical program we aimed to improve the affinity, physicochemical properties and metabolic stability exploring three regions of the hit. Systematic variation of different amines at position 4 (region I) led to the identification of 4-methyl-piperidinyl analogues. Substituents of the quinoline core (region II) and the phenylsulfonyl moiety (region III) were mapped by parallel synthesis. Evaluation of both morpholino- and 4-methyl-piperidinyl-sulfoquinoline libraries of about 270 derivatives revealed beneficial substituent combinations in regions II and III. Blood levels of optimized 4-methyl-piperidinyl-sulfoquinolines, however, were still insufficient for robust in vivo efficacy. Finally, introducing 4-hydoxymethyl-piperidinyl substituent to region I resulted in new sulfoquinolines with greatly improved solubility and reasonable affinity coupled with affordable metabolic stability. The most promising analogues (24 and 25) showed high blood levels and demonstrated significant efficacy in the experimental model of anxiety.
|
Authors | János Galambos, Attila Bielik, Gábor Wágner, György Domány, János Kóti, Zoltán Béni, Áron Szigetvári, Zsuzsanna Sánta, Zoltán Orgován, Amrita Bobok, Béla Kiss, Mónika L Mikó-Bakk, Mónika Vastag, Katalin Sághy, Mikhail Krasavin, Krisztina Gál, István Greiner, Zsolt Szombathelyi, György M Keserű |
Journal | European journal of medicinal chemistry
(Eur J Med Chem)
Vol. 133
Pg. 240-254
(Jun 16 2017)
ISSN: 1768-3254 [Electronic] France |
PMID | 28390229
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Piperazines
- Quinolines
- Receptor, Metabotropic Glutamate 5
|
Topics |
- Allosteric Regulation
(drug effects)
- Amination
- Animals
- Humans
- Piperazines
(chemistry, pharmacology)
- Quinolines
(chemistry, pharmacology)
- Rats, Wistar
- Receptor, Metabotropic Glutamate 5
(antagonists & inhibitors, metabolism)
|